OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform.
Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform than patients who received treatment normally. The AI platform used software algorithms on smartphones to confirm patient identity, medication and medication ingestion.
Read the full release here
Related Content:
News